Helena Woroniecka

Woroniecka is currently focused on coordinating clinical trials in Alzheimer’s disease is developing a deeper understanding of the clinical research landscape. Prior to entering the clinical space, she spent five years studying cell signaling pathways that regulate directed cell migration, with applications to cancer metastasis. This experience sparked a lasting interest in oncology and the molecular mechanisms underlying human disease. She is particularly interested in leveraging insights from basic science, clinical investigation and emerging technologies to improve our understanding of disease pathogenesis and therapeutic development.